HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jung-Ok Ban Selected Research

UK 101

9/2012Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jung-Ok Ban Research Topics

Disease

1Inflammation (Inflammations)
02/2015
1Necrosis
02/2015
1Neoplasms (Cancer)
09/2012

Drug/Important Bio-Agent (IBA)

1Acetaminophen (Paracetamol)FDA LinkGeneric
02/2015
1Chemokine CCL5IBA
02/2015
1CC ChemokinesIBA
02/2015
1Alanine Transaminase (SGPT)IBA
02/2015
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2015
1Eosine Yellowish-(YS) (Eosin)IBA
02/2015
1Hematoxylin (Haematoxylon)IBA
02/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2012
1UK 101IBA
09/2012
1epoxomicinIBA
09/2012